Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (PINL:NVIVQ)

InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury

Business Wire March 9, 2023

InVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules

Business Wire October 11, 2022

InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules

Business Wire October 7, 2022

InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference

Business Wire September 9, 2022

InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel

Business Wire July 13, 2022

InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery

Business Wire June 8, 2022

InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study

Business Wire June 2, 2022

InVivo Therapeutics Announces Reverse Stock Split

Business Wire April 14, 2022

InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference

Business Wire January 6, 2022
View More News ››

Opinion & Analysis (PINL:NVIVQ)

Cutting-edge devices and diagnostics deliver drugs and profits: Cantor Fitzgerald's Caroline Corner

George S. Mack July 31, 2015
View More Opinion ››

Bullboard Posts (PINL:NVIVQ)

US Companies Moving the Markets, Morning edition <br>Wed, Fe

Breaking News: $NVIV US Companies Moving the Markets, Morning edition Wed, Feb 07, 2024 as of 10.00 am ETA look at the top 10 most...
whytestocks - February 7, 2024

NVIV ..... is this starting a new trend?

Well.....all I know is.... that was a N.H.O.D with Volume increasing Tight share structure is meaningful With a swipe of a pen these...
Iseneschal - March 9, 2023

NVIV.... Not pumping this...just telling it....

the way I see it. ; ) Make note: The last time NVIV traded any volume was last Aug & again on Oct 2022...
Iseneschal - March 9, 2023

NVIV..... Alot has changed in 5 months.... NR this a.m....

and it was n't good news for the shareholders. However.....the Share Structure is still good ( I will be doing some research to...
Iseneschal - March 9, 2023

NVIV ....P.O announced this a.m

They sure know how to ruin a good party !!!   InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement...
Iseneschal - October 7, 2022

NVIV.....did you see the Price action today ????

Huge and on low volume......halted and traded higher in AH  WOW
Iseneschal - October 6, 2022
View more Bullboard ››

Kane Biotech Inc.

Kane Biotech Inc.

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and ...
View More »